TTLA EClips

line

TTLA HomeSearch Litigation BankAbout

January 06, 2012

spacer image

Consumer Group Questions Review of Breast Implants

Suit Filed Over Fatal Buttocks Surgery

J&J Said to Agree to Pay $1B in Risperdal Marketing Probe

Report Finds Most Errors at Hospitals Go Unreported

 

 

This Service Sponsored Exclusively by
The James Street Group

A Member Service of
Texas Trial Lawyers Association

 

line

Announcements

line

spacer image

 

Best Kept Trial Secrets: What Happens in Vegas Stays in Vegas

spacer image

Don't gamble with your cases. 48 hours in Vegas can change your practice forever! Join some of TTLA's battle-tested veterans and emerging superstars in Las Vegas for a CLE experience that'll change your luck in the courtroom. February 23-25, 2012, Bellagio Hotel, Las Vegas, 8 hrs. MCLE w/ 1 hr. Ethics  

 

Products

line

spacer image

 

Consumer Group Questions Review of Breast Implants

spacer image

Consumer safety advocates are questioning the Food and Drug Administration about seemingly incomplete and erroneous data used to affirm the safety of silicone breast implants last year. The FDA concluded last summer that the silicone-gel implants are basically safe as long as women understand they come with complications. More than one in five women who get implants for breast enhancement will need to have them replaced within five years, the agency's report concluded.  MATTHEW PERRONE, AP, Bloomberg  01/06/2012

Read Article: Bloomberg    

 

Laws/Cases

line

spacer image

 

Suit Filed Over Fatal Buttocks Surgery

spacer image

Two lawsuits have been filed over the death of a Las Vegas woman in a botched plastic surgery operation on her buttocks. Authorities say the Columbian couple that performed the surgery was operating an illegal medical practice in Las Vegas. The victim died after an "unusual reaction" to lidocaine, the Las Vegas Review Journal Reports. The defendants are currently serving four to eight years in prison for the woman's death.  Francis McCabe, Las Vegas Review Journal  01/04/2012

Read Article: Las Vegas Review Journal    

 

J&J Said to Agree to Pay $1B in Risperdal Marketing Probe

spacer image

Johnson & Johnson will pay more than $1 billion to the U.S. and most states to resolve a civil investigation into marketing of the antipsychotic Risperdal, according to people familiar with the matter. J&J, the world’s largest health products company, reached an agreement last week with the U.S. attorney in Philadelphia, according to the people, who weren’t authorized to speak about the matter. Negotiations over a possible criminal plea are still under way, they said. The U.S. government has been investigating Risperdal sales practices since 2004, including allegations the company marketed the drug for unapproved uses,  Margaret Cronin Fisk, Jef Feeley and David Voreacos , Bloomberg  01/06/2012

Read Article: Bloomberg    

 

Healthcare

line

spacer image

 

Report Finds Most Errors at Hospitals Go Unreported

spacer image

Hospital employees recognize and report only one out of seven errors, accidents and other events that harm Medicare patients while they are hospitalized, federal investigators say in a new report. Yet even after hospitals investigate preventable injuries and infections that have been reported, they rarely change their practices to prevent repetition of the “adverse events,” according to the study, from Daniel R. Levinson, inspector general of the Department of Health and Human Services.  Robert Pear, The New York Times  01/06/2012

Read Article: The New York Times    


The Plaintiff's Resource

line

Published by TRIALSMITH, Litigation Tools for Trial Lawyers
You received this email because you are subscribed to this service from your trial lawyers association.
• Unsubscribe  • Search National Litigation Bank  • 800-443-1757